TONIX PHARMACEUTICALS
Live / Applied — Non-final action mailed (as of 20 Oct 2025)
What this means for you
Not registered yet, but its 31 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98577945
- Mark type
- Stylized text
- Filed
- 31 May 2024
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, and for treating and preventing viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
Prior registrations
Prosecution history
- 23 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 20 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Oct 2025 — NON-FINAL ACTION E-MAILED
- 20 Oct 2025 — NON-FINAL ACTION WRITTEN
- 04 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Sept 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 18 Jul 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 Jul 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 May 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 05 May 2025 — FINAL REFUSAL E-MAILED
- 05 May 2025 — FINAL REFUSAL WRITTEN
- 14 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE